About Evidence-Based Immunology and Infectious Disease

Evidence-Based Immunology and Infectious Disease (EBIID), an indexed news publication from the publishers of The American Journal of Managed Care. The series seeks to promote exchanges among providers, payers, policy makers, and creators of therapies in disease areas that have significant effects on the healthcare system. The journal will primarily focus on AIDS/HIV, hepatitis-C, rheumatoid arthritis, and other autoimmune disorders. Our mission is to provide cutting-edge clinical, pharmacoeconomic, and regulatory information, so that payers, healthcare providers, and policy makers can make informed, evidence-based decisions to bridge the gap between the clinical and managed care realm. Our editorial board is a blend of clinicians, healthcare policy experts, public health officials, academic scientists, and health economists, ensuring a balanced discussion of the concerns that clinicians, policy makers, and payers face every day in disease management. Published four times a year, EBIID features a mix of clinical and industry news, original research, updates on new therapies, conference coverage, and the latest insights on healthcare reform. EBIID reaches a professional audience of clinical and policy decision-makers, including physicians, employers, payers, and government.

Submit to EBIID:

The US National Library of Medicine defines evidence-based medicine as “the process of systematically finding, appraising, and using contemporaneous research findings as the basis of clinical decisions. Evidence-based medicine asks questions, finds and appraises relevant data, and harnesses that information for everyday clinical practice.”

On this foundation, EBIID seeks high-quality commentaries and original research reports that provide cutting-edge clinical, pharmacoeconomic, and regulatory information to patients, clinicians, payers, health plans, and the pharmaceutical community. The editors are interested in papers that promote exchanges and facilitate communication among all stakeholders and healthcare policy makers that would potentially impact the efficiency and outcomes of AIDS/HIV, hepatitis-C, rheumatoid arthritis, and other autoimmune disorders. EBIID, launched in April 2014, aims to publishes articles that cover
  • drug pipelines
  • clinical trial results
  • diagnostic advances
  • targeted therapy
  • biomarker-aided personalized medicine
  • health policy (private, Medicare, and Medicaid)
  • regulatory policies
The content of EBIID is freely available online and does not require subscription, thus expanding the reach of the published data. We are an indexed publication but we do not undergo a rigorous peer-review process. Further, the contributing authors are not required to cover publication costs. If you wish to submit to EBIID, or have questions please contact: sgarimella@ajmc.com.

Editorial Board

Marissa Blum, MD, MS
Assistant Professor
Division of Rheumatology, School of Medicine
Temple University
Philadelphia, PA

Michael E. Chernew, PhD
Professor of Health Care Policy Harvard
Medical School
Harvard University
Boston, MA

Jeffrey D. Dunn, PharmD, MBA
Senior Vice President
VRx Pharmacy Services
Salt Lake City, UT

A. Mark Fendrick, MD
Professor of Medicine and Health Management and Policy Schools of Medicine & Health
University of Michigan
Ann Arbor, MI

Michael Horberg, MD, MAS, FACP, FIDSA
Executive Director Research and Community Benefit, Mid-Atlantic Permanente Medical Group
Director HIV/AIDS, Kaiser Permanente
Clinical Lead HIV/AIDS, Care Management Institute
Kaiser Permanente Mid-Atlantic Permanente Research Institute,
Rockville, MD

Eric A. Hughes, MD, Phd
Executive Director
HCV DAA Medical Lead
Global Clinical Research, Virology
Bristol-Myers Squibb

Princeton, NJ

Connie M. Jorstad
Director, Emerging Infections
Arlington, VA
Vyjayanthi Krishnan, PhD
Director, Vaccine Development
Vaxin Inc
Gaithersburg, MD
Richard Thompson, PharmD
Associate Professor and Chair
Department of Pharmacy Practice
Lipscomb University College of Pharmacy
Nashville, TN
Copyright AJMC 2006-2018 Clinical Care Targeted Communications Group, LLC. All Rights Reserved.
Welcome to the new and improved AJMC.com, the premier managed markets network. Tell us about yourself so that we can serve you better.
Sign Up

Sign In

Not a member? Sign up now!